ABT
Abbott Laboratories (ABT)
Healthcare • NYSE • $84.32-3.09%
- Symbol
- ABT
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $84.32
- Daily Change
- -3.09%
- Market Cap
- $146.87B
- Trailing P/E
- 23.62
- Forward P/E
- 13.91
- 52W High
- $139.06
- 52W Low
- $84.08
- Analyst Target
- $118.64
- Dividend Yield
- +2.99%
- Beta
- 0.65
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides…
Company websiteResearch ABT on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.